Teishima, J.; Inoue, S.; Hayashi, T.; Mita, K.; Hasegawa, Y.; Kato, M.; Kajiwara, M.; Shigeta, M.; Maruyama, S.; Moriyama, H.; Fujiwara, S. Impact of the Systemic Immune-Inflammation Index for the Prediction of Prognosis and Modification of the Risk Model in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors. CUAJ 2020, 14, E582-7.